Will Mifepristone Be Recalled If Texas Ruling Remains In Effect? Biopharma Leaders Back FDA

 
• By Brenda Sandburg
Bridge and uncertainty
The mifepristone ruling creates uncertainty for the FDA and industry. • Source: Shutterstock

More from US FDA

More from Agency Leadership